Eiger BioPharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2012 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $5.28M, a 51.1% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $5.28M +$1.78M +51.1% Dec 31, 2023 10-K 2024-04-08
Q4 2022 $3.49M +$1.54M +79.1% Dec 31, 2022 10-K 2024-04-08
Q4 2021 $1.95M +$1.5M +332% Dec 31, 2021 10-K 2024-04-08
Q4 2020 $451K -$2.83M -86.2% Dec 31, 2020 10-K 2023-03-17
Q4 2019 $3.28M -$1.36M -29.3% Dec 31, 2019 10-K 2023-03-17
Q4 2018 $4.63M +$1.42M +44% Dec 31, 2018 10-K 2022-03-10
Q4 2017 $3.22M +$1.39M +75.8% Dec 31, 2017 10-K 2021-03-09
Q4 2016 $1.83M +$1.43M +353% Dec 31, 2016 10-K 2020-03-13
Q4 2015 $404K +$305K +308% Dec 31, 2015 10-K 2019-03-14
Q4 2014 $99K +$2K +2.06% Dec 31, 2014 10-K 2018-03-09
Q4 2013 $97K +$2K +2.11% Dec 31, 2013 10-K 2017-03-23
Q4 2012 $95K Dec 31, 2012 8-K/A 2016-06-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.